368 related articles for article (PubMed ID: 15569700)
1. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing.
Lutchman Singh K; Davies M; Chatterjee R
Hum Reprod Update; 2005; 11(1):69-89. PubMed ID: 15569700
[TBL] [Abstract][Full Text] [Related]
2. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
3. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan.
Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN
Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148
[TBL] [Abstract][Full Text] [Related]
4. Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy.
Das M; Shehata F; Son WY; Tulandi T; Holzer H
Hum Reprod; 2012 Aug; 27(8):2509-14. PubMed ID: 22617122
[TBL] [Abstract][Full Text] [Related]
5. Ovarian reserve.
Coccia ME; Rizzello F
Ann N Y Acad Sci; 2008 Apr; 1127():27-30. PubMed ID: 18443326
[TBL] [Abstract][Full Text] [Related]
6. Dehydroepiandrosterone supplementation improves predictive markers for diminished ovarian reserve: serum AMH, inhibin B and antral follicle count.
Yilmaz N; Uygur D; Inal H; Gorkem U; Cicek N; Mollamahmutoglu L
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):257-60. PubMed ID: 23664458
[TBL] [Abstract][Full Text] [Related]
7. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment.
Janse F; Donnez J; Anckaert E; de Jong FH; Fauser BC; Dolmans MM
J Clin Endocrinol Metab; 2011 Apr; 96(4):1136-44. PubMed ID: 21289248
[TBL] [Abstract][Full Text] [Related]
8. Long-term effects of childhood cancer treatment on hormonal and ultrasound markers of ovarian reserve.
van den Berg MH; Overbeek A; Lambalk CB; Kaspers GJL; Bresters D; van den Heuvel-Eibrink MM; Kremer LC; Loonen JJ; van der Pal HJ; Ronckers CM; Tissing WJE; Versluys AB; van der Heiden-van der Loo M; Heijboer AC; Hauptmann M; Twisk JWR; Laven JSE; Beerendonk CCM; van Leeuwen FE; van Dulmen-den Broeder E;
Hum Reprod; 2018 Aug; 33(8):1474-1488. PubMed ID: 29982673
[TBL] [Abstract][Full Text] [Related]
9. Fertility preservation in childhood and adolescent female tumor survivors.
Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
[TBL] [Abstract][Full Text] [Related]
10. Testing ovarian reserve to predict age at menopause.
Lambalk CB; van Disseldorp J; de Koning CH; Broekmans FJ
Maturitas; 2009 Aug; 63(4):280-91. PubMed ID: 19631481
[TBL] [Abstract][Full Text] [Related]
11. [Statement: cancer treatments and ovarian reserve].
Basille C; Torre A; Grynberg M; Gallot V; Frydman R; Fanchin R
J Gynecol Obstet Biol Reprod (Paris); 2010 Oct; 39(6):433-43. PubMed ID: 20674192
[TBL] [Abstract][Full Text] [Related]
12. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors.
Lunsford AJ; Whelan K; McCormick K; McLaren JF
Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876
[TBL] [Abstract][Full Text] [Related]
13. Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.
Wenners A; Grambach J; Koss J; Maass N; Jonat W; Schmutzler A; Mundhenke C
BMC Cancer; 2017 Sep; 17(1):632. PubMed ID: 28877720
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced damage to ovary: mechanisms and clinical impact.
Bedoschi G; Navarro PA; Oktay K
Future Oncol; 2016 Oct; 12(20):2333-44. PubMed ID: 27402553
[TBL] [Abstract][Full Text] [Related]
15. Assessment of ovarian reserve in adult childhood cancer survivors using anti-Müllerian hormone.
Lie Fong S; Laven JS; Hakvoort-Cammel FG; Schipper I; Visser JA; Themmen AP; de Jong FH; van den Heuvel-Eibrink MM
Hum Reprod; 2009 Apr; 24(4):982-90. PubMed ID: 19153092
[TBL] [Abstract][Full Text] [Related]
16. Infertility in reproductive-age female cancer survivors.
Levine JM; Kelvin JF; Quinn GP; Gracia CR
Cancer; 2015 May; 121(10):1532-9. PubMed ID: 25649243
[TBL] [Abstract][Full Text] [Related]
17. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
18. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
[TBL] [Abstract][Full Text] [Related]
19. Tests for ovarian reserve: reliability and utility.
Domingues TS; Rocha AM; Serafini PC
Curr Opin Obstet Gynecol; 2010 Aug; 22(4):271-6. PubMed ID: 20543692
[TBL] [Abstract][Full Text] [Related]
20. Fertility preservation options for women with malignancies.
Marhhom E; Cohen I
Obstet Gynecol Surv; 2007 Jan; 62(1):58-72. PubMed ID: 17176489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
